CTMX
CytomX Therapeutics Inc
NASDAQ: CTMX · HEALTHCARE · BIOTECHNOLOGY
$4.05
-1.70% today
Updated 2026-04-29
Market cap
$951.18M
P/E ratio
—
P/S ratio
12.48x
EPS (TTM)
$-0.15
Dividend yield
—
52W range
$1 – $8
Volume
7.6M
CytomX Therapeutics Inc (CTMX) Financial statements
SEC filings — annual and quarterly data.
Income statement — annual
| Item | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $888000.00 | $5.08M | $7.71M | $15.04M | $71.62M | $59.50M | $57.49M | $68.43M | $69.57M | $53.16M | $101.21M | $138.10M | $76.20M |
| Revenue growth (YoY) | — | +471.7% | +51.9% | +95.1% | +376.1% | -16.9% | -3.4% | +19.0% | +1.7% | -23.6% | +90.4% | +36.4% | -44.8% |
| Cost of revenue | $15.19M | $34.06M | $39.71M | $72.90M | $105.54M | $0.00 | — | — | $5.84M | $5.86M | $2.17M | $1.77M | — |
| Gross profit | $888000.00 | $5.08M | $7.71M | $15.04M | $71.62M | $59.50M | $57.49M | $68.43M | $69.57M | $53.16M | $101.21M | $138.10M | $76.20M |
| Gross margin | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% |
| R&D | $10.89M | $28.30M | $28.36M | $54.76M | $92.28M | $103.87M | $131.62M | $112.94M | $114.19M | $111.65M | $77.68M | $83.38M | $65.80M |
| SG&A | $4.95M | $6.54M | $12.56M | $19.87M | $25.61M | $33.51M | $36.77M | $36.03M | $39.16M | $42.85M | $30.02M | $29.73M | $29.84M |
| Operating income | $-14.96M | $-29.77M | $-33.20M | $-59.59M | $-46.26M | $-77.87M | $-110.89M | $-80.54M | $-83.78M | $-101.33M | $-6.48M | $25.00M | $-19.56M |
| Operating margin | -1684.2% | -586.3% | -430.5% | -396.1% | -64.6% | -130.9% | -192.9% | -117.7% | -120.4% | -190.6% | -6.4% | 18.1% | -25.7% |
| EBITDA | $-14.22M | $-29.03M | $-32.43M | $-57.85M | $-41.97M | $-75.99M | $-108.29M | $-77.97M | $-81.08M | $-98.89M | $-4.31M | $26.76M | $-18.19M |
| EBITDA margin | -1601.8% | -571.8% | -420.5% | -384.6% | -58.6% | -127.7% | -188.4% | -113.9% | -116.5% | -186.0% | -4.3% | 19.4% | -23.9% |
| EBIT | $-14.88M | $-29.81M | $-33.63M | $-59.59M | $-43.61M | $-77.87M | $-110.89M | $-80.54M | $-83.78M | $-101.33M | $-6.48M | $25.00M | $-19.56M |
| Interest expense | $254000.00 | $487000.00 | $1.73M | $1.69M | $0.00 | $0.00 | $10.84M | $1.81M | $172000.00 | $2.02M | — | — | — |
| Income tax | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Effective tax rate | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Net income | $-15.14M | $-30.31M | $-35.37M | $-58.90M | $-43.10M | $-84.60M | $-102.24M | $-64.82M | $-80.65M | $-97.30M | $-569000.00 | $31.87M | $-17.37M |
| Net income growth (YoY) | — | -100.2% | -16.7% | -66.5% | +26.8% | -96.3% | -20.8% | +36.6% | -24.4% | -20.6% | +99.4% | +5700.9% | -154.5% |
| Profit margin | -1705.3% | -597.0% | -458.7% | -391.5% | -60.2% | -142.2% | -177.8% | -94.7% | -115.9% | -183.0% | -0.6% | 23.1% | -22.8% |